메뉴 건너뛰기




Volumn 202, Issue 4, 2013, Pages 257-258

Progress in VZV vaccination? Some concerns

Author keywords

Herpes zoster; Vaccination strategy; Vaccines; Varicella

Indexed keywords

VARICELLA ZOSTER VACCINE;

EID: 84881316059     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-013-0298-x     Document Type: Review
Times cited : (10)

References (13)
  • 1
    • 0035900514 scopus 로고    scopus 로고
    • Untersuchungen zur immunitätslage der impfpräventablen kinderkrankheiten röteln, masern, mumps und windpocken
    • DOI 10.1055/s-2001-18475
    • Buxbaum S, Doerr HW, Allwinn R (2001) Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox. Dtsch Med Wochenschr 126(46):1289-1293 (Pubitemid 33086842)
    • (2001) Deutsche Medizinische Wochenschrift , vol.126 , Issue.46 , pp. 1289-1293
    • Buxbaum, S.1    Doerr, H.W.2    Allwinn, R.3
  • 2
    • 0035850977 scopus 로고    scopus 로고
    • Seroprevalence of varicella-zoster virus in the German population
    • DOI 10.1016/S0264-410X(01)00276-6, PII S0264410X01002766
    • Wutzler P, Färber I, Wagenpfeil S, Bisanz H, Tischer A (2001) Seroprevalence of varicella-zoster virus in the German population. Vaccine 20:121-124 (Pubitemid 32905323)
    • (2001) Vaccine , vol.20 , Issue.1-2 , pp. 121-124
    • Wutzler, P.1    Farber, I.2    Wagenpfeil, S.3    Bisanz, H.4    Tischer, A.5
  • 3
    • 79952056451 scopus 로고    scopus 로고
    • Varicella-zoster virus
    • Springer, New York
    • Abendroth A et al. (eds) (2010) Varicella-zoster virus. Curr Top Microbiol Immunol, vol. 342, Springer, New York
    • (2010) Curr Top Microbiol Immunol , vol.342
    • Abendroth, A.1
  • 4
    • 84879049693 scopus 로고    scopus 로고
    • Herpes zoster - Recent aspects of diagnosis and control
    • Karger Press, Basel
    • Gross G, Doerr HW (ed) (2006) Herpes zoster - recent aspects of diagnosis and control. Monographs in virology, vol. 26. Karger Press, Basel
    • (2006) Monographs in Virology , vol.26
    • Gross, G.1    Doerr, H.W.2
  • 5
    • 84865786639 scopus 로고    scopus 로고
    • Varicella vaccines
    • 22859715 10.1093/bmb/lds019 1:CAS:528:DC%2BC38XhtlWlsr7I
    • Flatt A, Breuer J (2012) Varicella vaccines. Br Med Bull 103:115-127
    • (2012) Br Med Bull , vol.103 , pp. 115-127
    • Flatt, A.1    Breuer, J.2
  • 6
    • 77954724459 scopus 로고    scopus 로고
    • Zoster vaccine - Current status and future prospects
    • 20550454 10.1086/653605
    • Oxman MN (2010) Zoster vaccine - current status and future prospects. Clin Infect Dis 51:197-213
    • (2010) Clin Infect Dis , vol.51 , pp. 197-213
    • Oxman, M.N.1
  • 7
    • 84881312247 scopus 로고    scopus 로고
    • Epidemiology of Herpes Zoster: What has changed?
    • 10.1159/000096269
    • Allwinn R, Buxbaum S, Doerr HW (2006) Epidemiology of Herpes Zoster: what has changed? Monogr Virol 26:154-163
    • (2006) Monogr Virol , vol.26 , pp. 154-163
    • Allwinn, R.1    Buxbaum, S.2    Doerr, H.W.3
  • 8
    • 84856317428 scopus 로고    scopus 로고
    • The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom
    • 22119592 10.1016/j.vaccine.2011.11.026
    • Van Hoek AJ, Melegano A, Gay N, Bilcke J, Edmunds WJ (2012) The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine 30:1225-1234
    • (2012) Vaccine , vol.30 , pp. 1225-1234
    • Van Hoek, A.J.1    Melegano, A.2    Gay, N.3    Bilcke, J.4    Edmunds, W.J.5
  • 9
    • 0034659990 scopus 로고    scopus 로고
    • Analysis of varicella vaccine breakthrough rates: Implications for the effectiveness of immunisation programmes
    • PII S0264410X00001006
    • Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G (2000) Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine 18:2775-2778 (Pubitemid 30254462)
    • (2000) Vaccine , vol.18 , Issue.25 , pp. 2775-2778
    • Brisson, M.1    Edmunds, W.J.2    Gay, N.J.3    Law, B.4    De Serres, G.5
  • 12
    • 84875405390 scopus 로고    scopus 로고
    • Review of the US varicella vaccination program. Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the antilope valley varicella active surveillance project data
    • (Epub ahead of print)
    • Goldman PS, King PG (2012) Review of the US varicella vaccination program. Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the antilope valley varicella active surveillance project data. Vaccine (Epub ahead of print)
    • (2012) Vaccine
    • Goldman, P.S.1    King, P.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.